Hudson Rachel E, Tomczak Dexter J, Kaufman Emily L, Adams Ashlee M, Carroll Jeffery A, Broadway Paul R, Ballou Michael A, Richeson John T
Department of Agricultural Sciences, West Texas A&M University, Canyon, TX 79016, USA.
Livestock Issues Research Unit, USDA-ARS, Lubbock, TX 79403, USA.
Animals (Basel). 2020 Jun 30;10(7):1119. doi: 10.3390/ani10071119.
The study objective was to determine if a combined weaning and transportation stress model affected performance, antibody, endocrine, or hematological responses to modified-live virus (MLV) or killed virus (KV) respiratory vaccination in beef steers. In total, 48 calves (Day 0 BW = 226 ± 6.2 kg) from a single origin were used in a 2 × 2 factorial to evaluate main effects of stress model, vaccine type, and their interaction, resulting in four treatments ( = 12/treatment) including non-stress control (C) with KV (CKV), C with MLV (CMLV), stress model implementation (S) with KV (SKV), and S with MLV (SMLV). The C calves were weaned at the origin ranch on Day -37 and transported 472 km to the study site on Day -21 to allow acclimation. The S calves were weaned on Day -3, transported 460 km to a research facility on Day -2, held overnight, and transported 164 km to the study site on Day -1 to mimic the beef cattle marketing process. Vaccines were administered on Day 0 and KV was revaccinated on Day 14. The animal was the experimental unit and dependent variables were analyzed using PROC MIXED with repeated measures (day). A stress model effect ( = 0.01) existed for DMI from Day 0 to Day 7 with greater DMI for C (6.19 vs. 4.64 kg/day) when compared to S. The MLV groups had reduced ( = 0.05) ADG from Day 0 to Day 56, compared to KV. There was a vaccine type × day ( < 0.01) interaction with increased ( ≤ 0.01) PI3V- and IBRV-specific antibody titers for KV on Day 21; conversely, MLV had increased ( ≤ 0.01) BVDV titers on Days 14, 28, 35, 42, 49, and 56. Increased ( ≤ 0.05) BRSV titers were observed in a stress model × day ( < 0.01) interaction for S on Days 21, 28, 36, and 42; however, C exceeded S in BVDV-specific antibody concentration on Days 21, 28, and 49. A day effect ( < 0.01) was observed for serum haptoglobin with the greatest ( < 0.01) concentration on Day 3. Serum cortisol concentration was greater ( ≤ 0.04) for C vs. S on Days -2, 0, 1, 3, and 5. Total leukocytes were decreased for C vs. S on Days 0, 1, 3, 5, 7, 14, and 21 ( ≤ 0.02). A reduction ( ≤ 0.04) in total leukocytes was observed for MLV on Days 5, 7, and 14 vs. KV. Neutrophils and neutrophil:lymphocyte were markedly increased ( ≤ 0.01) for S on Day -2, whereas neutrophils were decreased ( ≤ 0.01) on Days 1 and 21 for S. Monocytes were decreased on Days 1, 5 and 7 for MLV ( ≤ 0.04) and Days -2 to 14 for S ( ≤ 0.03). Eosinophils were reduced ( = 0.007) for S vs. C on Day -2, yet a distinct rebound response ( = 0.03) was noted for S on Day 0. The results indicate that S and MLV vaccination more profoundly induced immunomodulation in beef calves.
本研究的目的是确定联合断奶和运输应激模型是否会影响肉牛对改良活病毒(MLV)或灭活病毒(KV)呼吸道疫苗接种的性能、抗体、内分泌或血液学反应。总共48头来自单一来源的犊牛(第0天体重=226±6.2千克)用于2×2析因试验,以评估应激模型、疫苗类型及其相互作用的主要影响,产生四种处理(每组n = 12),包括接种KV的非应激对照(C)组(CKV)、接种MLV的C组(CMLV)、接种KV的应激模型组(S)(SKV)和接种MLV的S组(SMLV)。C组犊牛在第-37天在原牧场断奶,并在第-21天运输472公里至研究地点以使其适应环境。S组犊牛在第-3天断奶,在第-2天运输460公里至研究设施,过夜饲养,并在第-1天运输164公里至研究地点,以模拟肉牛销售过程。在第0天接种疫苗,并在第14天对KV进行再次接种。以动物为实验单位,使用PROC MIXED程序对重复测量数据(天数)的相关依赖变量进行分析。从第0天到第7天,存在应激模型效应(P = 0.01),与S组相比,C组的干物质采食量(DMI)更高(6.19对4.64千克/天)。与KV组相比,MLV组在第0天到第56天的平均日增重(ADG)降低(P = 0.05)。在第21天,存在疫苗类型×天数(P < 0.01)的相互作用,KV组的PI3V和IBRV特异性抗体滴度升高(P≤0.01);相反,MLV组在第14、28、35、42、49和56天的BVDV滴度升高(P≤0.01)。在第21、28、36和42天,观察到S组在应激模型×天数(P < 0.01)的相互作用中BRSV滴度升高(P≤0.05);然而,在第21、28和49天,C组的BVDV特异性抗体浓度超过S组。血清触珠蛋白存在天数效应(P < 0.01),在第3天浓度最高(P < 0.01)。在第-2、0、1、3和5天,C组的血清皮质醇浓度高于S组(P≤0.04)。在第0、1、3、5、7、14和21天,C组的总白细胞数低于S组(P≤0.02)。与KV组相比,MLV组在第5、7和14天的总白细胞数减少(P≤0.04)。在第-2天,S组的中性粒细胞和中性粒细胞:淋巴细胞比值显著升高(P≤0.01),而在第1天和第21天,S组的中性粒细胞减少(P≤0.01)。在第1、5和7天,MLV组的单核细胞减少(P≤0.04),在第-2天至第14天,S组的单核细胞减少(P≤0.03)。在第-2天,S组的嗜酸性粒细胞低于C组(P = 0.007),但在第0天,S组出现明显的反弹反应(P = 0.03)。结果表明,S组和MLV疫苗接种在肉牛犊中更显著地诱导了免疫调节。